Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin vs Metformin in PCOS
NCT06140108Phase 3Completed
- Sponsor
- SINA Health Education and Welfare Trust
- Start
- Dec 2023
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of empagliflozin in polycystic ovary syndrome (PCOS), sponsored by SINA Health Education and Welfare Trust. Started Dec 2023; status: completed.
02
Drugs
empagliflozin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT06140108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06140108.